Condition: Triple Negative Breast Cancer · Non Small Cell Lung Cancer · Metastatic Breast Cancer · Sponsor: Memorial Sloan Kettering Cancer Center
This study is being done to determine if stereotactic body radiotherapy (SBRT) when delivered to all sites of disease in participants with 1-5 metastases will increase the length of time before participants' disease gets worse.
This description comes directly from the study's public registry record.
Amy Xu, MD, PhD · 646-888-6863 · xua@mskcc.org
Wanqing Zhi, MD, PhD · 631-623-4246 · zhiw@mskcc.org
Always discuss trial participation with your own doctor first.
| Natera, Inc. (Data and Specimen Analysis Only) | San Carlos, California, United States | Not Yet Recruiting |
| Hartford Healthcare | Hartford, Connecticut, United States | Recruiting |
| WCHN Norwalk Hospital - Data Collection | Norwalk, Connecticut, United States | Recruiting |
| Baptist Alliance - McI | Miami, Florida, United States | Recruiting |
| Memorial Sloan Kettering Basking Ridge | Basking Ridge, New Jersey, United States | Recruiting |
| Memorial Sloan Kettering Monmouth | Middletown, New Jersey, United States | Recruiting |
| Memorial Sloan Kettering Bergen | Montvale, New Jersey, United States | Recruiting |
| Memorial Sloan Kettering Cancer Center @ Commack | Commack, New York, United States | Recruiting |
| Memorial Sloan Kettering Westchester | Harrison, New York, United States | Recruiting |
| Memorial Sloan Kettering Cancer Center | New York, New York, United States | Recruiting |
| Memorial Sloan Kettering Nassau | Uniondale, New York, United States | Recruiting |
| Lehigh Valley Health Network | Allentown, Pennsylvania, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03808337